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Anterior capsule staining using 0.025% trypan blue in
cataracts without red reflex
Purpose: To describe the use of anterior capsule staining in cataracts
without red reflex using a 0.025% trypan blue solution.  Methods: Six
eyes of 6 patients with cataracts without red reflex were submitted to
phacoemulsification using a direct injection of 0.2 to 0.5 ml of 0.025%
trypan blue in the anterior chamber previous to viscoelastic injection.
All patients had an ophthalmologic examination prior to surgery, as well
as pre and postoperative corneal endothelial cell count.  Results: In all
cases the capsule became stained with a faint blue color that enabled
an adequate visibility of the flap during the continuous curvilinear
anterior capsulotomy (CCC). There were no intra-or postoperative
complications. The endothelial cell loss varied between 1.8% and 26.6%
(mean 12.8%). Conclusion: Staining the anterior capsule with 0.025%
trypan blue solution allows a good visibility of the capsular flap and
facilitates the confection of CCC in cataracts without red reflex.
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INTRODUCTION
The continuous circular capsulotomy (CCC) that was introduced by
Gimbel and Neuhann(1) in 1990 is resistant to radial tears during the various
surgical steps and also offers the advantages of in the bag intraocular lens
(IOL) implantation. Another advantage of CCC is the opportunity of a safe
sulcus IOL implantation over the anterior capsule rim in cases of a posterior
capsule rupture. For a good control when performing a CCC, the visuali-
zation of the anterior capsular flap is necessary and the lack of an adequate
red reflex renders the technique very difficult.
Many techniques have been proposed to help the surgeon to perform a
CCC in cataracts without red reflex(2-9).
The purpose of this report is to describe the use of 0.025% trypan blue
solution to allow better anterior capsular flap visibility and a safe CCC in
cataracts without red reflex. Trypan blue has classically been used to
identify damaged endothelial cells and safety has been proved in donor
corneal buttons(10), as well as in extracapsular cataract extraction(11).
METHODS
Six eyes of 6 patients with cataracts without red reflex and no further
known ocular disease were submitted to phacoemulsification and IOL im-
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plantation. The ages varied between 52 and 79 years (mean
68). All surgeries were done by the same surgeon (LLF), using
the same equipment (Leggacy 20 000 - Alcon), under peribul-
bar anesthesia, with a three-plane clear corneal incision, the
“stop and chop”(12) technique and an implant with a 5.25 mm
optical zone.
After the ancillary paracenthesis, made in the limbus 90º
away from the area where the clear cornea incision should be
done, 0.2 to 0.5 ml of 0.025% trypan blue was injected in the
anterior chamber, followed by filling of the anterior chamber
with a viscoelastic solution, leaving the anterior capsule with
a faint blue coloration. After the clear corneal incision, CCC
was performed using the Ultrata forceps. The 0.025% trypan
blue solution was obtained by diluting 0.1 ml of the 0.1%
commercially available solution (Ophthalmos - São Paulo, Bra-
zil) in 0.3 ml of balanced salt solution (BSS, Alcon). The total
effective used ultrasound power was recorded for each case.
At the end of surgery dexametasone and gentamicin were
injected in the subconjunctival space. Patients were seen on
the 1st, 6th, 30th and 40th postoperative day and received a
combination of 1 mg dexametasone, 5 mg neomicine sulfate
and 6000 IU polymyxin B sulfate eyedrops (Maxitrol - Alcon)
6 times a day in the first postoperative week with gradual
tapering of the dose in the following 3 weeks.
All patients had visual acuity, intraocular pressure (IOP)
and anterior chamber reaction evaluated before surgery and
on days 1, 6, 30 and 40. Endothelial cell count was performed
prior to surgery and on day forty.
RESULTS
CCC was successfully performed in all eyes. In 2 of them it
was necessary to inject more viscoelastic after the initial cap-
sular puncture because of liquefied cortical material leakage.
The contrast between the stained capsular flap and the white
cortical material allowed a safe control of the CCC progression
and the remaining anterior capsule edge was still stained du-
ring phacosculpture. By the time of cortical aspiration, the
faint blue coloration had disappeared from the anterior capsu-
le rim. The remaining surgical steps were uneventful.
On the first postoperative day, mild corneal edema was
seen in 1 eye and moderate edema in 5 eyes. By the 6th posto-
perative day the edema had vanished in all cases. There was
no increase in IOP or any evidence of residual stain in the
anterior segment during the postoperative period. A mild (+)
cellular anterior chamber reaction was present on day 1 in the
6 eyes and had disappeared by day 6.
The visual acuity, IOP and endothelial cell count before
surgery and on day 40 are showed in Table 1. The endothelial
cell loss varied between 1.85 to 26.6% (mean of 12.8%).
DISCUSSION
Many techniques have been suggested to improve safety
in CCC confection of cataracts without red reflex, such as the
use of a optic fiber endoilluminator in a lateral position(7),
endodiathermy(5), air filling of the anterior chamber(2), two-
step CCC under high magnification(3), autologous blood im-
pregnation(8) and the injection of various vital stains in the
anterior chamber like a solution of gentian violet and methy-
lene blue, brilliant cresyl blue, fluorescein, trypan blue 0.1%
and indocianine green(4,6,9). The endoilluminator and the endo-
diathermy imply in additional costs with sophisticated de-
vices, and the endodiathermy capsulotomy is considered
weaker than the traditional CCC(5). The two-step CCC involves
a change in the emulsification technique to work within a small
CCC and the additional risk of a radial tear or peripheral escape
during the enlargement of the primary CCC.
 Among the vital stains, brilliant cresyl blue has never
been used in vivo; the gentian violet and methyilene blue
solutions result in corneal edema and endothelial decompen-
sation(9), fluorescein must be injected underneath the anterior
capsule, staining the lens epithelium, not the capsule itself(4)
and it can stain the cornea and lens cortex also(6). Indocianine
green seems to be a good option(6), but it is expensive, not
available in a fractionated fashion, has a life span of only 8
hours after dilution and must be kept protected from light.
Trypan blue is a vital stain classically used to evaluate
damaged endothelial cells, presenting no toxicity in concen-
trations as high as 0.3%(11). Since it does not stain the healthy
endothelial cells, it poses no risk of lowering intraoperative
visibility. The safety of intraoperative use of trypan blue in
extracapsular cataract surgery has already been proved with
follow-up periods up to 8 years(11).
 Recently Melles et al.(9) reported the use of 0.1% trypan
blue to perform CCC in cataracts without red reflex. They
advocated the use of an air bubble in the anterior chamber
with injection of the stain between the air and the anterior
capsule to prevent its dilution(9). We used the injection of a
0.025% solution without an air bubble in the chamber and
achieved sufficient capsular staining. Injecting the dye bet-
ween an air bubble and the capsule is not a easy maneuver and
the size of the bubble is critical, since it can prevent the
complete staining of the anterior capsule. CCC was safely
Table 1. Visual acuity, IOP and endothelial cell count in the pre-
operative period and 40th postoperative day
Patient      Vision         Pressure       Endothelial   Endothelial      US/
          cell count      cell loss seconds
Initial Final Initial Final Initial Final %
1 CF 4M 20/30 16 12 2791 2654 4,9 7,8
2 CF40cm 20/20 12 12 2492 1830 26,6 16,2
3 HM 20/20 18 14 2398 2211 7,8 12,6
4 HM 20/30 14 15 2428 2383 1,85 4,8
5 HM 20/20 12 12 2967 2678 9,75 16,8
6 20/200 20/25 12 12 2328 1718 26,2 13,2
* CF = count fingers; M = meters; cm = centimeters; HM = hand motions; US
= ultrasound energy
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performed with postoperative corneal findings similar to those
usually seen in surgeries without it. Additionally, using a so-
lution that is diluted starting from its original commercial
presentation, without performance decay, represents a cost
reduction that is an important goal of present medicine.
Another possible application of capsular staining is in the
training of new surgeons, since the improvement in flap visibi-
lity may help to control its progression for beginners even
when the cataract has a good red reflex.
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RESUMO
Objetivo: Relatar o uso de uma solução de azul tripano a
0,025% para corar a cápsula anterior em cataratas sem reflexo.
Métodos: Seis olhos de 6 pacientes portadores de catarata sem
reflexo foram submetidos à facoemulsificação com injeção di-
reta de azul tripano a 0,025% na câmara anterior previamente à
injeção de solução viscoelástica. Todos os pacientes tiveram
exame oftalmológico prévio à cirurgia incluindo contagem de
células endoteliais no pré-operatório e no 40º dia pós-operató-
rio. Resultados: Em todos os casos a cápsula anterior adquiriu
uma tonalidade azul clara que permitiu uma boa visibilidade e
controle da progressão durante a capsulotomia curvilínea
contínua (CCC). Não houve complicação intra ou pós-opera-
tória. A perda endotelial variou entre 1,8% e 26,6% (média
12,8%). Conclusão: O uso de azul tripano a 0,025% para corar
a cápsula anterior permite uma boa visibilidade do "flap",
facilitando a confecção da CCC em cataratas sem reflexo.
Descritores: Catarata; Extração de catarata; Cápsula do
cristalino; cristalino/cirurgia; Corantes; Azul tripano/uso
terapêutico; Capsulotomia
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